Recently, Jin et al. found that glycyrrhetinic acid, which has a mitochondrial-targeting function, inhibits serine hydroxymethyltransferase 2 (SHMT2), a mitochondrial enzyme, thereby downregulating mitochondrial OXPHOS and fatty acid β-oxidation and inhibiting cancer cell proliferation and growth [208]. The gene discussed is SHMT2; the disease is cancer.